Validation of Diffuse Correlation Spectroscopic Measurement of Cerebral Blood Flow Using Phase-Encoded Velocity Mapping Magnetic Resonance Imaging by Buckley, Erin M et al.
University of Pennsylvania
ScholarlyCommons
Department of Physics Papers Department of Physics
4-17-2012
Validation of Diffuse Correlation Spectroscopic
Measurement of Cerebral Blood Flow Using Phase-
Encoded Velocity Mapping Magnetic Resonance
Imaging
Erin M. Buckley
University of Pennsylvania, Children's Hospital of Philadelphia
Dalton Hance
University of Pennsylvania
Thomas Pawlowski
Children's Hospital of Philadelphia
Jennifer Lynch
University of Pennsylvania
Felice B. Wilson
Children's Hospital of Philadelphia
See next page for additional authors
Follow this and additional works at: http://repository.upenn.edu/physics_papers
Part of the Physics Commons
Buckley E. M., Hance D., Pawlowski T., et al. (2012) Validation of diffuse correlation spectroscopic measurement of cerebral blood flow using phase-
encoded velocity mapping magnetic resonance imaging. Journal of Biomedical Optics, 17(3):037007-1-037007-8. doi: 10.1117/1.JBO.17.3.037007
Copyright 2012 Society of Photo-Optical Instrumentation Engineers. One print or electronic copy may be made for personal use only. Systematic
reproduction and distribution, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper
are prohibited.
This paper is posted at ScholarlyCommons. http://repository.upenn.edu/physics_papers/273
For more information, please contact repository@pobox.upenn.edu.
Recommended Citation
Buckley, E. M., Hance, D., Pawlowski, T., Lynch, J., Wilson, F. B., Mesquita, R. C., Durduran, T., Diaz, L. K., Putt, M. E., Licht, D. J.,
Fogel, M. A., & Yodh, A. G. (2012). Validation of Diffuse Correlation Spectroscopic Measurement of Cerebral Blood Flow Using
Phase-Encoded Velocity Mapping Magnetic Resonance Imaging. Retrieved from http://repository.upenn.edu/physics_papers/273
Validation of Diffuse Correlation Spectroscopic Measurement of Cerebral
Blood Flow Using Phase-Encoded Velocity Mapping Magnetic Resonance
Imaging
Abstract
Diffuse correlation spectroscopy (DCS) is a novel optical technique that appears to be an excellent tool for
assessing cerebral blood flow in a continuous and non-invasive manner at the bedside. We present new clinical
validation of the DCS methodology by demonstrating strong agreement between DCS indices of relative
cerebral blood flow and indices based on phase-encoded velocity mapping magnetic resonance imaging
(VENC MRI) of relative blood flow in the jugular veins and superior vena cava. Data were acquired from 46
children with single ventricle cardiac lesions during a hypercapnia intervention. Significant increases in
cerebral blood flow, measured both by DCS and by VENC MRI, as well as significant increases in
oxyhemoglobin concentration, and total hemoglobin concentration, were observed during hypercapnia.
Comparison of blood flow changes measured by VENC MRI in the jugular veins and by DCS revealed a
strong linear relationship, R = 0.88, p < 0.001, slope = 0.91 ± 0.07. Similar correlations were observed between
DCS and VENC MRI in the superior vena cava, R = 0.77, slope = 0.99 ± 0.12, p < 0.001. The relationship
between VENC MRI in the aorta and DCS, a negative control, was weakly correlated, R = 0.46, slope = 1.77 ±
0.45, p < 0.001.
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Abstract. Diffuse correlation spectroscopy (DCS) is a novel optical technique that appears to be an excellent tool for
assessing cerebral blood flow in a continuous and non-invasive manner at the bedside. We present new clinical
validation of the DCS methodology by demonstrating strong agreement between DCS indices of relative cerebral
blood flow and indices based on phase-encoded velocity mapping magnetic resonance imaging (VENC MRI) of
relative blood flow in the jugular veins and superior vena cava. Data were acquired from 46 children with single
ventricle cardiac lesions during a hypercapnia intervention. Significant increases in cerebral blood flow, measured
both by DCS and by VENC MRI, as well as significant increases in oxyhemoglobin concentration, and total
hemoglobin concentration, were observed during hypercapnia. Comparison of blood flow changes measured
by VENC MRI in the jugular veins and by DCS revealed a strong linear relationship, R ¼ 0.88, p < 0.001,
slope ¼ 0.91 0.07. Similar correlations were observed between DCS and VENC MRI in the superior vena
cava, R ¼ 0.77, slope ¼ 0.99 0.12, p < 0.001. The relationship between VENC MRI in the aorta and DCS, a
negative control, was weakly correlated, R ¼ 0.46, slope ¼ 1.77 0.45, p < 0.001. © 2012 Society of Photo-Optical Instru-
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1 Introduction
Assuring adequate tissue perfusion is central for support of
patients in the critical care arena. In particular, information
about cerebral blood flow is valuable for assessment of brain
perfusion and prevention of secondary injury. Very few technol-
ogies, however, provide clinicians with bedside access to this
information. Current cerebral perfusion diagnostics, such as
transcranial Doppler ultrasound, arterial spin-labeled magnetic
resonance imaging (MRI), Xenon-133 clearance, and positron
emission tomography, are either low-throughput, indirect,
expensive, invasive, or require patient transport.1,2 Diffuse cor-
relation spectroscopy (DCS), is a novel optical technique that
appears to be an excellent tool for assessing cerebral blood flow
in a continuous and non-invasive manner at the bedside. The
technique, however, must be validated in a variety of clinical
settings and against numerous well-established blood flow mod-
alities in order for this new optical tool to gain wide acceptance.
Patients with congenital heart defects represent one popula-
tion that could benefit from a non-invasive bedside monitor of
cerebral blood flow. Recent work has shown that whencompared
to healthy full-term children, patients with complex congenital
heart defects have a high incidence of peri-operative brain injury
and a significantly higher incidence of neurocognitive impair-
ments.3–5 During periods of hemodynamic instability, such as
peri-operative care, a monitor of cerebral blood flow could
provide insight into the timing, development, and evolution
of these brain injuries.
DCS6–9 has shown promise as a monitor of relative changes
in cerebral blood flow.10–16 The DCS technique uses near-
infrared, NIR, light in the tissue absorption windowto probe the
dynamics of deep tissues. Within this window scattering, rather
than absorption, dominates photon transport, so that near-
infrared light experiences thousands of scattering events and
propagates centimeters into the tissue before it is either detected
at the tissue surface or lost due to absorption. DCS monitors
changes in blood flow by capturing temporal fluctuations of
scattered light detected at the tissue surface.10 These temporalAddress all correspondence to: Erin M. Buckley, University of Pennsylvania,
Department of Physics and Astronomy, 3231 Walnut Street, Philadelphia, Penn-
sylvania 19104. Tel: (215) 573-6406; Fax: (215) 573-6391; E-mail: ebuckle2@sas
.upenn.edu. 0091-3286/2012/$25.00 © 2012 SPIE
Journal of Biomedical Optics 17(3), 037007 (March 2012)
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light intensity fluctuations are sensitive to blood flow in the
tissue microvasculature and such measurements can be made
in a continuous fashion with data acquisition rates of 0.3 Hz
and even faster.15
The present contribution validates DCS measurement of
relative changes in cerebral blood flow (CBF) against a well-
established magnetic resonance technique known as phase
encoded velocity mapping (VENC MRI). VENC MRI does not
measure cerebral blood flow in the brain; rather, it measures
blood flow in the main vessel supplying blood to the brain, the
aortic arch, and blood flow in the main vessels draining blood
from the brain, the right and left common jugular veins, and the
superior vena cava. These measures of flow in the jugular veins
have been shown to agree with other measures of cerebral blood
flow. These measures of flow in the jugular veins have been
shown to agree strongly with other measures of cerebral
blood flow.17,18 However, while VENC MRI provides high-
quality, reliable blood flow data, these measurements must be
carried out in an MRI scanner making them unsuitable for con-
tinuous monitoring. We find that relative changes of blood flow
in the jugular veins and superior vena cava correlate strongly
with relative changes in CBF measured with DCS. Additionally,
we find that blood flow changes in the aorta, a negative control,
were only weakly correlated with relative changes in CBF mea-
sured with DCS. These results indicate DCS may be employed
as a continuous bedside monitor of CBF in patients with con-
genital heart defects as well as in a wide variety of other patients.
2 Materials and Methods
Children with single ventricle complex congenital heart defects
at The Children’s Hospital of Philadelphia were recruited
for this study and approved by the Institutional Review
Board. All measurements were performed on the morning of
the child’s staged cardiac surgery. Immediately prior to surgery,
general anesthesia was induced via mask inhalation of sevoflur-
ane. After intravenous access was obtained, pancuronium
0.2 mg∕kg was administered for neuromuscular blockade and
a nasal endotracheal tube was then placed. The patient was sub-
sequently mechanically ventilated, utilizing 1% to 2% sevoflur-
ane for maintenance of general anesthesia while an arterial
catheter was placed in an upper extremity. Patients were brought
to the MRI scanner and a non-invasive optical probe was placed
on the forehead for continuous optical monitoring. Figure 1
shows the experimental timeline. Briefly, after a 30-min baseline
period of ventilation with FiO2, fraction inspired oxygen, of
0.21, inspired CO2 was added to the room air mixture to achieve
a FiCO2 of approximately 0.039. The CO2 mixture remained on
for a 30-min hypercapnic period to allow for gas equilibration
and stabilization of the higher hypercapnic blood flow. During
this period of equilibration, anatomical brain MRI was obtained.
Non-invasive, cuff blood pressures, electrocardiogram, periph-
eral oxygen saturation, and FiCO2 were monitored and recorded
throughout the duration of the study. Arterial blood gases were
obtained at the start of the baseline period and at the end of the
hypercapnia period to assess changes in partial pressure of
carbon dioxide, pCO2, in the blood.
2.1 Phase Encoded Velocity Mapping MRI
To measure blood flow in the main vessels supplying and
draining from the brain, a magnetic resonance technique
known as phase-encoded velocity mapping, VENC MRI, was
employed.19–21 In brief, the technique relies on the fact that mag-
netic spins of intravascular protons flowing along a magnetic
field acquire a phase-shift that is linearly proportional to their
velocity:
Δφ ¼ γvδAg: (1)
In Eq. (1), Δφ is the phase-shift, γ is the gyromagnetic ratio,
v is the velocity, δ is the time between the centers of two
magnetic pulses, and Ag is the area of one of the gradient
pulses. A magnetic field gradient is aligned along the axis
of the vessels of interest, namely the aorta, jugular veins,
and superior vena cava, thereby inducing a phase shift in
spins that move or flow along this gradient. The phase
shift accumulated by the MRI signal obtained from a specific
voxel is proportional to the velocity within that voxel. The
direction of flow is aligned with the use of oblique magnetic
field gradients. Combined with phase error correction tech-
niques, velocity is accurately measured.
Our investigation used a Siemens 1.5-Tesla Avanto MRI
system, manufactured by Siemens Medical Systems, Malvern,
New Jersey. After localizers in multiple planes, a stack of static,
steady-state free precession axial images were acquired span-
ning the entire thorax and neck. These images evaluated cardi-
ovascular anatomy and were used for localized through-plane
velocity mapping. The effective repetition time was the R-R
interval (range 450 to 650 ms). The echo time was 1.5 to
3 ms, the number of segments per heartbeat was 29, the number
of excitations was 3, the image matrix size was 128 × 128 pix-
els, interpolated to 256 × 256, with a field of view ranging from
180 to 200 mm and slice thickness of 3 mm. Multiplanar recon-
struction, a software package resident on the Siemens MRI
system, used the transverse images to calculate the exact slice
position and double-oblique angles to obtain a ventricular out-
flow tract view and long-axis images of the jugular veins and
superior vena cava. If two ventricular outflow tracts were
present, each one was obtained separately. An imaging plane
perpendicular to flow was then determined for the ventricular
outflow tract at the sinotubular junction, right and left common
jugular veins above the superior vena cava and the superior vena
cava proximal to the pulmonary artery anastomosis and distal to
the innominate and subclavian veins. The retrospective phase
encoded velocity mapping sequence was then performed with
a repetition time of 35 ms, echo time of 3 ms, number of
segments per heartbeat of 3, field of view of 180 mm, a slice
thickness of 5 mm, obtaining 20 to 23 phases depending
upon the heart rate utilizing parallel imaging and 5 averages.
VENC MRI encoding was 60 to 90 cm∕ sec .
Fig. 1 Timeline of hypercapnia protocol. The patient inhaled room air
for 30 min at which point CO2 was added to the gas mixture for a frac-
tion of inspired CO2 of approximately 3%.
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Quantitative velocities were obtained in a region of interest
(ROI) that was semi-automatically traced along the margins of
the blood vessels of interest. Blood flow was computed by the
sum of the product of the velocities measured in each pixel and
the area of each pixel in the ROI. By integrating this flow over
the cardiac cycle and multiplying by the heart rate, we obtained
an average blood flow in units of liters per minute. The protocol
not only included VENC MRI, but also a contiguous stack of
static, steady state free precession images in the axial plane. This
stack was used to locate the exact slice positions for VENCMRI
so that this plane was perpendicular to flow.
For each patient, velocity maps were obtained at the sinotub-
ular junction in the aortic root, in the left and right common
jugular veins, and in the superior vena cava during room air
inhalation and during hypercapnia as seen in Figs. 1 and 2.
From these maps, we calculated a net flow, as described
above, per cardiac cycle. The signal was averaged over multiple
cardiac cycles to minimize effects of respiratory motion.
Averaging also had the advantage of improving the signal-to-
noise ratio, yielding an average blood flow value for each vessel
acquired over approximately 1 min. Thus, we obtained a mean
blood flow with units of liters/minute in the aorta (BFAorta),
superior vena cava (BFSVC), and by summing the blood flow
in the right and left common jugulars, the jugular veins
(BFJug). Relative changes in blood flow (rBF) through these
vessels due to hypercapnia were computed using the following
formula: rBF ¼ ðBFCO2∕BFRoom AirÞ × 100%. Cerebrovascular
reactivity (CVR), defined as the change in blood flow divided
by the change in partial pressure of CO2 (ΔpCO2), was com-
puted as CVR ¼ ðrBF − 100%Þ∕ΔpCO2.
2.2 Diffuse Optical and Correlation Spectroscopies
Optical measurements of changes in oxy- and deoxy-hemoglobin
concentration (ΔHb and ΔHbO2, respectively) and relative
changes in cerebral blood flow (rCBF) were obtained continu-
ously with a custom-made optical probe, manufactured by Fiber-
optic Systems, Inc., Simi Valley, California. The probe contained
two separate source-detector pairs, one for diffuse optical spectro-
scopy (DOS) andone forDCS, both separated by2.5 cm; thus, the
mean penetration depth of diffusing photons reached into the cor-
tical tissues. TheDCS detector was a bundle of eight single-mode
fibers used to improve the signal-to-noise ratio. The probe was
securedgently to the foreheadwith a soft headwrap.Additionally,
a fiducialmarkerwasplacedover theprobetolocate fiberpositions
on anatomical MRI images.
Optical data were acquired using a hybrid diffuse optical
spectrometer consisting of a commercially available DOS sys-
tem (Imagent, ISS, Champaign, Illinois) and a diffuse correla-
tion spectrometer custom-made in our laboratory. The DOS
instrument operates in the frequency domain at 110 MHz
with three wavelengths, 686, 786, and 826 nm. It uses a hetero-
dyne detection at 5 kHz to quantify diffusive wave AC
amplitude attenuation, phase shift, and average DC value of
the detected light. For DOS data analysis, the modified
Beer-Lambert law,22,23 was employed to compute changes in
the absorption coefficient, ΔμaðλÞ:
log½IðλÞ∕I0ðλÞ ¼ r × DPFðλÞ × ΔμaðλÞ; (2)
μaðλÞ is linearly dependent on the changes in concentrations
of oxy- and deoxy-hemoglobin (ΔHbO2 and ΔHb, respec-
tively).24 In Eq. (2), IðλÞ is the AC light intensity measured
at wavelength λ and time t, I0ðλÞ is the mean AC light inten-
sity measured at wavelength λ during the 5 min of room air
inhalation when VENCMRI scans were obtained, DPFðλÞ is
the wavelength dependent diffuse pathlength factor account-
ing for the increase in photon pathlength due to multiple
scattering, equal to 5.4, 5.0, and 4.7 for 686, 786, and
826 nm, respectively,25 and r is the DOS source detector
separation distance (2.5 cm for this experiment). If the
detected AC light intensity was outside the linear range of
our instrument, the DOS data were excluded from our ana-
lysis. Note, the measured DC amplitude attenuation and
phase-shift were not employed in this analysis.
The DCS instrument uses a long-coherence-length laser,
CrystaLaser, RCL-080-785S, operating at 785 nm to deliver
coherent light to the tissue. Light is detected at the tissue surface
with a bundle of eight single-mode detection fibers and is trans-
mitted to a fast photon counting avalanche photodiode that
outputs a TTL signal for every photon detected. A custom
built 8-channel correlator board (FLEX03OEM-8CH, correla-
tor.com, Bridgewater, New Jersey) uses this TTL signal to
derive the intensity autocorrelation function based on the photon
arrival times.26
For DCS analysis, we employed the semi-infinite homoge-
neous medium solution to the correlation diffusion equation to
fit our measured intensity autocorrelation curves, g2ðτÞ, for a
blood flow index (BFI). BFI is related to the motion of red
blood cells and their concentration.10 DCS data were discarded
if the intensity (i.e., photon count rate) of all detectors was less
than 5 kHz (i.e., if the intensity signal-to-noise ratio was less
than 10). Intensity autocorrelation curves were fit for BFI
using fminsearchbnd.m, (Matlab 2010a, MathWorks) to find
Fig. 2 (Top) Phase encoded velocity mapping magnitude (a, b) and
phase (c, d) images of the jugular veins taken during baseline (left)
and hypercapnia (right). (Bottom) Sample time series of optical data.
DOS measures of ΔHb and ΔHbO2 are shown on the top by dotted
line and open circle, respectively, while DCS measures of rCBF are
shown on the bottom. The grey shading indicates the time of the velo-
city mapping scans. Mean DCS data were acquired in these regions for
comparison to VENC MRI results.
Buckley et al.: Validation of diffuse correlation spectroscopic measurement : : :
Journal of Biomedical Optics 037007-3 March 2012 • Vol. 17(3)
Downloaded from SPIE Digital Library on 30 May 2012 to 130.91.117.41. Terms of Use:  http://spiedl.org/terms
the optimal solution to the objective function, f , where f is
defined as
f ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Σi
h
g2ðτiÞFit − g2ðτiÞMeasured
i
2
r
: (3)
The fitting procedure assumes an initial value of μa and μ 0s ,
(0.1 cm−1 and 9 cm−1, respectively, at 785 nm) for all
patients.27 The reduced scattering coefficient, μ 0s , was
assumed to remain constant, but the measured changes in
μa at 786 nm computed with the DOS setup were incorpo-
rated into each fit of g2ðτÞ. Additionally, we fit the data
assuming the mean squared displacement of the moving scat-
terers obeys a Brownian motion model. In this case, the lead-
ing exponential decay rate of g2ðτÞ should be proportional to
the sq uare root of the correlation time, τ.7,10,24
For comparison with velocity mapping MRI data, a mean
relative change in CBF obtained by DCS was calculated for
each patient. A mean and standard deviation of the blood
flow index, hBFIi and σBFI respectively, were computed during
the approximately 5-min long room air and hypercapnia velocity
mapping scans. We defined the relative change in CBF due to
hypercapnia as rCBFDCS ¼ ðhBFIiCO2∕hBFIiRoom AirÞ × 100%,
where the subscript indicates data acquired during the
hypercapnic or room air velocity mapping MRI scan.
Additionally, erebrovascular reactivity, CVR, was defined as
CVR ¼ ðrCBFDCS − 100%Þ∕ΔpCO2.
2.3 Statistical Analysis
To test the hypothesis that each of the relative variables differed
from room air during hypercapnia, we carried out a Wilcoxon
signed rank test.28 Analyses used R 2.11,29 hypotheses tests and
associated p-values (p) were two-sided. Statistical significance
was declared for p-values <0.05.
To quantify the relationship between relative changes in
blood flow in the jugular veins, superior vena cava, and
aorta measured by velocity mapping MRI against relative
changes in cerebral blood flow measured by DCS, we fit a
simple linear regression model and estimated Pearson’s
correlation coefficient. Pearson’s correlation, R, varies from
0 to 1.0 and measures the extent to which a linear model
explains variability in the data. Note that R can approach
1.0, even for a case where the slope of the line between
the two measures varied substantially from unity. We used
Lin’s concordance correlation coefficient, CCC, to measure
agreement between the two measures. The CCC is the product
of Pearson’s R, a measure of precision, and a bias correction
factor which reflects the degree that the linear association
between two variables differs from 45 deg through the origin.
For example, R ¼ CCC∕Bias Correction. Bland-Altman plots
of the difference versus the mean of the two measures of rela-
tive flow changes were constructed as a graphical approach
to assessing agreement.30
3 Results
Fifty-three children with single ventricle congenital heart
defects were recruited. All patients were scheduled for cardiac
surgical repair on the day of the study. Fifty-two patients com-
pleted the entire study, one was eliminated due to time
constraints. Forty-six out of 52 remaining patients satisfied
the inclusion criteria of having high-quality DOS, DCS, and
VENC MRI data. Table 1 lists the median and interquartile
range values of patient age, weight, height, skull/scalp/CSF
thickness, sex, and surgical procedure for the study cohort.
Patients had a median age of 2.8 years and were largely
male, 70%.
Figure 2 shows velocity mapping MRI and DOS/DCS data
from a typical subject. The top images show the phase maps
of the region in and around the right and left common jugular
veins during the room air, left, and hypercapnia, right. The
veins are circled in white for ease of viewing. It is evident
that during hypercapnia, the phase contrast in both vessels
increases, indicating an increase in velocity in these vessels.
The middle and bottom portions of Fig. 2 show the contin-
uous time trace of DOS measures of ΔHb and ΔHbO2, mid-
dle, and DCS measures of rCBF, bottom. The shaded grey
regions indicate the time periods in which VENC MRI
scans were taken. For comparison between DCS and VENC
MRI, the DCS data were averaged over the grey shaded
regions to extract an average rCBF due to hypercapnia for
each patient.
Table 2 summarizes the median and interquartile range of
both the baseline, room air, and changes due to hypercapnia
in all physiological parameters of interest. Since the DOS
and DCS measures were all relative to the room air baseline,
we report only changes for all variables. Hypercapnia induced
significant, p < 0.01, increases in CBF as measured by DCS and
by phase-encoded velocity mapping MRI. Additionally, hyper-
capnia led to significant increases in heart rate, mean arterial
blood pressure, oxy- and total hemoglobin concentration, and
pCO2. Arterial pH decreased significantly with CO2 administra-
tion, and no population-averaged changes were observed
in de-oxyhemoglobin concentration changes.
As seen in Fig. 3 and summarized in Table 3, a comparison of
phase encoded velocity mapping MRI measures of relative
changes in cardiac output in the superior vena cava to DCS mea-
sures of changes in cerebral blood flow were linearly related
with high Pearson and concordance correlation coefficients,
R ¼ 0.77, CCC ¼ 0.74, and a slope (95% CI) of 0.99 (0.74,
1.23). A similar correlation to DCS flow changes was observed
with MRI measures of relative changes in cardiac output in the
jugular vein, R ¼ 0.88, CCC ¼ 0.87, slope ð95%CIÞ ¼ 0.91
ð0.75; 1.05Þ. Weaker correlations were also observed between
rBF in the aorta and rCBF from DCS with a slope (95% CI)
of 1.77 (0.72, 2.51) (p < 0.001).
Table 1 Patient demographics. Average skull, scalp, and CSF thick-
ness was computed underneath the optical probe using anatomical MRI
images.
Median (IQR)
Age (yrs) 2.8 (3.0)
Weight (kg) 12.7 (8.0)
Height (cm) 91.3 (30.5)
Sex (Male:Female) 32:14
Skull/scalp/CSF thickness (cm) 0.81 (0.28)
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4 Discussion
We observed significant agreement between changes in CBF
measured with diffuse correlation spectroscopy and changes
in blood flow in the common jugular veins and superior
vena cava measured with VENC MRI. Although the two tech-
niques measure entirely different vascular structures related to
cerebral hemodynamics, this strong agreement is encouraging.
DCS measures cerebral blood flow in the microvasculature.
The optical probe was secured to the forehead, thus, we
were monitoring changes in CBF at the surface of the frontal
cortex. VENC MRI measures blood flow in the jugular veins
and superior vena cava, both of which are capacitance vessels
that accommodate the large volume of blood flowing through
them. Hypercapnia induces significant global changes in cere-
bral blood flow in the grey and white matter.31,32 Therefore, in
normal function, the micro vascular CBF changes in the frontal
cortex measured by DCS should represent similar changes
throughout the brain and these micro vascular changes should
also be reflected in the macro vascular changes in blood flow
drainage in the jugular veins.17,18 Naturally, this micro/macro
agreement presumes the patient has a healthy brain with no
regions of watershed or hypoxia that may cause the frontal cor-
tex to be a poor representation of the whole brain. Further, all
patients were studied under conditions of general anesthesia
with mechanical ventilation and neuromuscular blockade.
These conditions preclude regional activation of cerebral cor-
tex due to cognitive processes or movement.
This agreement between VENC MRI and DCS is encoura-
ging, as one of the major advantages of DCS is its portability.
Thus, by contrast to the sporadic CBF measures provided by
phase encoded velocity mapping MRI, these results suggest
DCS may be employed to accurately assess relative changes
in CBF in a continuous fashion at the patient’s bedside. DCS
may be a particularly attractive option for critically ill patients
who are difficult to transport safely to an MRI, patients
who are unable to have an MRI due to metallic implants,
and patients who would benefit from continuous CBF
monitoring.
A priori we would not expect changes in aortic flow due to
hypercapnia to accurately represent microvascular CBF changes
seen with DCS, thus, the weak correlation observed between
DCS and aortic flow is readily explained. Aortic blood flow
represents systemic blood flow, flow to both the brain and
the body. Since CBF represents only one portion of the total
cardiac output, we should expect the fractional change in
CBF from the aorta during hypercapnia to be dependent on cer-
ebrovascular reactivity as well as the geometry of the aortic arch
and its branches. Total flow changes to both body and brain
should match total aortic flow changes, however, the individual
components of brain and body flows alone will not necessarily
track aortic flow changes as not all tissues respond to CO2 in a
uniform way.
A handful of publications have studied the cerebral hemody-
namic effects of hypercapnia on patients with congenital heart
Table 2 Median (interquartile range) baseline values followed by median (interquartile range) changes due to hypercapnia, and p-values obtained by
Wilcoxon signed rank test.
Source Variable Baseline Change due to CO2 p-value
Arterial blood gas pH 7.39 (0.04) −0.18 (0.08) <0.001
pCO2 39 (6) mmHg þ31 (14) mmHg <0.001
EKG Heart rate 109 (21) bpm þ14 (13) bpm <0.001
Cuff Mean arterial pressure 60 (10) mmHg þ4 (20) mmHg 0.002
Transcutaneous SpO2 82 (10)% þ1 (6)% 0.40
Velocity mapping MRI BFAorta 3.05 ð0.93Þ L∕min þ126.2 (26.6)% <0.001
BFJugular 0.78 ð0.50Þ L∕min þ141.0 (46.4)% <0.001
BFSVC 0.99 ð0.42Þ L∕min þ135.5 (49.0)% <0.001
CVR-Aorta — þ1.0 ð1.0Þ%∕mmHg <0.001
CVR-Jug. — þ1.4 ð3.0Þ%∕mmHg <0.001
CVR-SVC — þ1.3 ð2.5Þ%∕mmHg <0.001
DCS CBF — þ148.5 (42.8)% <0.001
CVR — þ1.8 ð2.0Þ%∕mmHg 0.001
DOS Hb — −1.3 (5.4) μM 0.07
HbO2 — þ12.1 (5.1) μM <0.001
THC — þ10.1 (8.0) μM <0.001
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defects.11,33–36 Durduran et al.11 measured a mean, cerebrovas-
cular reactivity due to increased CO2 of 3.1%∕mmHg in
neonates with congenital heart defects using DCS. The popula-
tion studied in this work was considerably older than the
neonates previously studied, ranging in age from 3 months to
5 years old. In our population, we found a slightly lower
mean CO2 reactivity of 1.8%∕mmHg. Fogel et al.36 studied
older CHD patients with VENC-MRI during hypercapnia,
mean age of 2.2 years. They found a mean increase in jugular
flows of 230% with a mean change in pCO2 of 23 mmHg indi-
cating a cerebrovascular reactivity of approximately
5%∕mmHg. Our results fall within the published values for
this patient population of infants with congenital heart defects.
4.1 Optical Approximations
Due to limitations in probe size, we were restricted to a single
source-detector separation for DOS measurements. Thus, the
modified Beer-Lambert law was used to quantify changes in
the absorption coefficient and changes in oxy- and deoxy-
hemoglobin. However, assumptions are required to employ
the modified Beer-Lambert Law. In particular, it is assumed
that Δμa is small relative to its baseline value and we assume
that μ 0s remains constant. These assumptions appear to be
valid in the present experiment. On average, Δμa at 786 nm
was 0.015 cm−1, a change of approximately 15% of
the presumed baseline value of Δμa ¼ 0.1 cm−1 at 786 nm.
Similar results were found for 688 and 826 nm. Additionally,
although μ 0s was not explicitly measured in this experiment,
we feel justified in assuming μ 0s does not change due to hyper-
capnia.37 Red blood cells contribute very little to the total cell
volume of brain tissue, thus the majority of light scattering
events are most likely due to mitochondria and other organelles
as well as cell nuclei.38,39 Thus, even if the blood volume
increases substantially due to hypercapnia, this increase
would have a small effect on the net scattering coefficient.
To fit the DCS data for a blood flow index, we assumed
initial values for the absorption and reduced scattering coeffi-
cients, μa and μ 0s . Because we are only interested in relative
changes in the BFI, our choice of initial μa and μ 0s has little
to no effect on the resulting value of rCBF. However, changes
from these initial values of μa and μ 0s that occur during the dura-
tion of the study may influence the magnitude of rCBF. Thus,
we incorporated changes in μa obtained with DOS into our fit-
ting procedure for BFI. However, as mentioned previously, our
DOS analysis assumed that the scattering coefficient remained
constant during the duration of the study. This assumption is
most likely valid for hypercapnia. If false, a 10% increase in
the scattering coefficient could alter the magnitude of rCBF
by approximately 20%. Thus, future work would benefit greatly
from the use of multiple source detector DOS amplitude and
phase measurements used to continuously quantify μa and μ 0s .
We have anatomical brain images of each patient, and we
computed the mean skull/scalp/CSF thickness underneath our
optical probe to be 0.81 cm. Because of the 2.5 cm source-detec-
tor separations used for both DOS and DCS, photons travel on
average a depth of 1 cm into the tissue. Thus, we are confident
the optical measurements are probing the surface of the cortex.
However, in the future, DCS quantification of rCBF can be
further improved. A semi-infinite model was used to fit DCS
data and the fits were restricted to the early delay times, wherein
g2ðτÞ > 1.2, to isolate contributions from photons penetrating
deeply into tissue. As known from the anatomical scans, this
model greatly simplifies the head geometry of these patients.
In reality, the scalp, skull, cerebral spinal fluid, grey matter,
and white matter possess different optical properties that can
be accounted for in Monte Carlo simulations of light propaga-
tion.40–42 Although the semi-infinite model can be improved
upon, it provides a sufficient approximation for this pilot study.
Fig. 3 (Top) Changes in blood flow (rBF) measured with velocity map-
ping MRI in the jugular veins (left), superior vena cava (middle), and
aorta (right) compared to rCBFDCS. The solid line represents the best-fit
line to the data, while the dashed line indicates the line of perfect con-
cordance. The grey ribbon denotes the 95% confidence interval for
the mean rCBFDCS. (Bottom) Bland-Altman plots of the difference in
rBF, measured with VENC-MRI, and rCBF, measured with DCS, versus
the mean of these parameters. Solid horizontal lines indicate the mean
difference between each VENC parameter and rCBF measured with
DCS, while the dotted lines indicate the 95% limits of agreement.
Table 3 Summary of concordance correlation coefficients (CCC) and bias correction factor, along with the estimated slope and intercept for a linear
regression between DCS measures of rCBF and phase encoded velocity mapping rBF and the adjusted R2 and p-values.
Site CCC Bias correction Slope estimate (95% CI) Intercept estimate (95% CI) [%] R, p-value
Jugular veins 0.87 1.00 0.91 (0.75, 1.05) 15.3 (−9.1, 39.7) 0.88, p < 0.001
Superior vena cava 0.74 0.95 0.99 (0.74, 1.23) 11.4 (−25.9, 48.6) 0.77, p < 0.001
Aorta 0.20 0.42 1.77 (0.72, 2.51) −62.2 (−159.1, 66.8) 0.46, p < 0.001
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4.2 MRI Assumptions
VENCMRI is a very accurate technique that does not depend on
assumptions of flow profiles. Nevertheless, eddy currents and
higher order Maxwell terms can introduce errors into the mea-
surements. In addition, if a blood vessel is tortuous, flow may
not be perpendicular to the imaging plane and this may intro-
duce errors as well. Finally, partial volume effects will average
out velocities in a given voxel, decreasing the accuracy of the
measurement. In our study, eddy currents and Maxwell terms
were minimized and the authors took great pains to ensure
the imaging plane was perpendicular to flow. The dimensions
of our VENC MRI images were 1 × 1 × 5 mm, which was
well within accepted norms. Prior to each MRI scan, phantoms
were used to calibrate the system.
5 Conclusion
In this paper, we demonstrate a highly significant correlation
between measures of relative changes in cerebral blood flow
derived with diffuse correlation spectroscopy and relative
changes in blood flow in the common jugular veins and superior
vena cava in pediatric patients with congenital heart defects.
This agreement further strengthens the promise of DCS as an
accurate and non-invasive modality for continuous CBF moni-
toring at the bedside.
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